Repetitive transcranial magnetic stimulation increases serum brain-derived neurotrophic factor and decreases interleukin-1β and tumor necrosis factor-α in elderly patients with refractory depression

Epigenetic mechanisms underlying the role of brain-derived neurotrophic factor in depression and response to antidepressants

(2015) F. Duclot et al.   JOURNAL OF EXPERIMENTAL BIOLOGY

Resting state EEG and functional connectivity in patients with major depression and under electro-convulsive therapy

(2015) O Pogarell et al.   PHARMACOPSYCHIATRY

Refractory depression: mechanisms and evaluation of radically open dialectical behaviour therapy (RO-DBT) [REFRAMED]: protocol for randomised trial

(2015) T R Lynch et al.   BMJ Open

Effects of electroconvulsive therapy on serum levels of brain-derived neurotrophic factor and nerve growth factor in treatment resistant major depression

(2014) Ali Emrah Bilgen et al.   BRAIN RESEARCH BULLETIN

Serum Brain-derived neurotrophic factor levels in post-stroke depression

(2014) Jie Li et al.   JOURNAL OF AFFECTIVE DISORDERS

Chronic Administration of Infliximab (TNF-α Inhibitor) Decreases Depression and Anxiety-like Behaviour in Rat Model of Chronic Mild Stress

(2013) Ayşe Karson et al.   BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY

Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression

(2013) C. N. Haile et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Serial repetitive transcranial magnetic stimulation (rTMS) decreases BDNF serum levels in healthy male volunteers

(2013) Gerd Schaller et al.   JOURNAL OF NEURAL TRANSMISSION

Depression Treatment in Patients With General Medical Conditions: Results From the CO-MED Trial

(2012) D. W. Morris et al.   ANNALS OF FAMILY MEDICINE

Efficacy of Transcranial Magnetic Stimulation Targets for Depression Is Related to Intrinsic Functional Connectivity with the Subgenual Cingulate

(2012) Michael D. Fox et al.   BIOLOGICAL PSYCHIATRY

Epigenetics, Depression and Antidepressant Treatment

(2012) Andreas Menke et al.   CURRENT PHARMACEUTICAL DESIGN

Targeting IL-1 in depression

(2012) Michael Maes et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Depression Epidemiology and Its Treatment Evolution

(2012) Robert M. A. Hirschfeld   JOURNAL OF CLINICAL PSYCHIATRY

Deep Brain Stimulation for Treatment-Resistant Depression

(2012) Alexander S. Taghva et al.   World Neurosurgery

A Systematic Review of Treatments for Refractory Depression in Older People

(2011) Claudia Cooper et al.   AMERICAN JOURNAL OF PSYCHIATRY

Daily Left Prefrontal Repetitive Transcranial Magnetic Stimulation for Acute Treatment of Medication-Resistant Depression

(2011) Mark S. George et al.   AMERICAN JOURNAL OF PSYCHIATRY

Therapeutic options in treatment-resistant depression

(2011) Eduard Vieta et al.   ANNALS OF MEDICINE

The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response

(2011) N. Su et al.   BRAIN RESEARCH

Serum levels of brain-derived neurotrophic factor in major depressive disorder: state–trait issues, clinical features and pharmacological treatment

(2010) M L Molendijk et al.   MOLECULAR PSYCHIATRY

Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

(2009) M Bryant Howren et al.   PSYCHOSOMATIC MEDICINE

Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: No effects on brain-derived neurotrophic factor (BDNF) concentrations in serum

(2007) Undine E. Lang et al.   JOURNAL OF AFFECTIVE DISORDERS